Blog - Page 4047 of 5387

MondayNov 03, 2008 6:44 am

Goodrich Petroleum Corporation (NYSE: GDP)

Goodrich Petroleum Corporation (NYSE: GDP), an independent oil and gas company engaged in the exploration, exploitation, development and production of oil and natural gas properties, focuses its efforts on the Cotton Valley Trend of East Texas and Northwest Louisiana. As of December 31, 2007, the Company owned working interests in 301 active oil and gas wells located in 26 fields. Goodrich aims to provide long term growth through the growth and expansion of their oil and gas reserves and production. For further information, visit the Company's web site at www.goodrichpetroleum.com.

MondayNov 03, 2008 6:44 am

Globex Mining Enterprises Inc. (TSX: GMX CN)

Globex Mining Enterprises Inc. (TSX: GMX CN) has a very large portfolio of advanced properties that contain gold, copper, zinc, silver, uranium, platinum, palladium, magnesium, and talc potential. Currently, all of their properties are located within North America. The company aims to create value for stockholders by acquiring mineral properties, enhancing them, then developing them to production or in some cases sell the projects. For further information, visit the Company's web site at www.globexmining.com.

MondayNov 03, 2008 6:43 am

Global Med Technologies, Inc. (OTC BB: GLOB)

Global Med Technologies, Inc. (OTC BB: GLOB), an international medical software company, is focused on developing regulated and non-regulated software products and services for application in the medical field. The company’s products are currently deployed in 20 countries and serve more than 1,600 transfusion centers, blood banks and laboratories. Global Med’s U.S. division provides Vein-to- Vein® tracking through its Donor Doc(TM), SafeTrace®, SafeTrace Tx® and ElDorado Donor(TM) software products. For further information, visit the Company's web site at www.wyndgate.com.

MondayNov 03, 2008 6:42 am

Global Brands Acquisition Corporation (AMEX: GQN)

Global Brands Acquisition Corporation (AMEX: GQN) is a company organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock acquisition, stock purchase, reorganization or similar business combination, one or more operating business. The Company's efforts in identifying a prospective target business will not be limited to a particular industry although the Company will focus its efforts on acquiring an operating business in the branded consumer industry. Units of the young company were first listed on the AMEX on December 7, 2007. For further information, visit the company website at: www.enterpriseacq.com.

MondayNov 03, 2008 6:42 am

Glass Earth Gold Ltd. (TSX: GEL CN)

Glass Earth Gold Ltd. (TSX: GEL CN) is focused on discovering and developing gold and geothermal opportunities in New Zealand. Currently, the company is known to hold the largest on-shore gold exploration and prospecting permit portfolio in all of New Zealand. The company takes a scientific approach to gold exploration, leveraging its highly skilled international exploration team and the sophisticated use of new technology. For further information, visit the Company's web site at www.glassearthlimited.com.

MondayNov 03, 2008 6:41 am

Gilead Sciences, Inc. (NASDAQ: GILD)

Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, is focused on discovering, developing, and commercializing novel medicines to address unmet medical needs. The company’s aim is to improve the care of patients suffering from life-threatening diseases with every new discovery and experimental drug candidate. Primary areas of focus include: antivirals, cardiovascular conditions and respiratory diseases. For further information, visit the Company's web site at www.gilead.com.

MondayNov 03, 2008 6:40 am

Geron Corporation (NASDAQ: GERN)

Geron Corporation (NASDAQ: GERN) is a biopharmaceutical company focused on developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including heart failure, spinal cord injury and diabetes. The company’s mission is to develop an array of anti-cancer therapies based on telomerase inhibitors, telomerase therapeutic vaccines, and telomerase-based oncolytic viruses, and diagnostics based on telomerase detection. For further information, visit the Company's web site at www.geron.com.

MondayNov 03, 2008 6:40 am

GeoResources, Inc. (NASDAQ: GEOI)

GeoResources, Inc. (NASDAQ: GEOI) owns and operates producing oil and gas properties in the Gulf Coast, Permian Basin, Rocky Mountains and Williston Basin through its three subsidiaries G3 Operating, LLC and Southern Bay Operating, LLC. The company leverages its management’s expertise in mergers and acquisitions, which is further enhanced by relationships with investment and commercial bankers, institutional investors, brokers and principals. For further information, visit the Company's web site at www.georesourcesinc.com.

MondayNov 03, 2008 6:39 am

Geologix Explorations Inc. (TSX: GIX CN)

Geologix Explorations Inc. (TSX: GIX CN), a mineral exploration company, is committed to acquiring, exploring and developing gold properties in North and South America, as well as Mexico. Their projects include: San Agustin, La Casita, Consejo, Silver Cloud, QC Property, RO Property, OZ Property, Geologix-Newmont Alliance, Liscay Property, Cayhua, San Felipe, Sura, Patcorral, and Toro Blanco. The Company’s management has extensive expertise in the mining industry and have track record of brning early stage exploration prospects to final feasibility and ultimately to production. For further information, visit the Company's web site at http://www.geologix.ca.

MondayNov 03, 2008 6:39 am

Gentium S.p.A. (NASDAQ: GENT)

Gentium S.p.A. (NASDAQ: GENT), a biopharmaceutical company, specializes in discovering, researching, developing and manufacturing active ingredients derived from natural sources as potential therapeutic agents. The company focuses on developing relationships with industrial and academic institutions and intends to discover further beneficial effects of its products as well as develop pharmaceuticals with a broader range of treatment indications. For further information, visit the Company's web site at http://www.gentium.com.

Site Search

Company Search